🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to determine the effectiveness and s...
Status
Unknown
Location
Mack Eye Center
Start Date
2013-10
Trial ID
NCT02009709
Treatments Being Tested
A total of 22 subjects will be included in the study. The subjects who were...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06557447
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2019-04-01
Trial ID
NCT04534634
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Status
Unknown
Location
Shandong Second Provincial General Hospital
Start Date
2021-09-06
Trial ID
NCT05420493
Treatments Being Tested
Study Aim is creation of the Hospital Register of patients with heart failu...
Status
Active Not Recruiting
Location
Moscow State Clinical Hospital named after V.V. Veresaev
Start Date
2023-09-01
Trial ID
NCT06114498
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
RATIONALE: ABT-510 may stop the growth of melanoma by blocking blood flow t...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00602199
The purpose of this research is to identify biological characteristics occu...
Status
Recruiting
Location
Vanderbitl-Ingram Cancer Center
Start Date
2010-06-03
Trial ID
NCT01205815
Treatments Being Tested